284 related articles for article (PubMed ID: 26846307)
1. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition.
Huang D; Duan H; Huang H; Tong X; Han Y; Ru G; Qu L; Shou C; Zhao Z
Sci Rep; 2016 Feb; 6():20502. PubMed ID: 26846307
[TBL] [Abstract][Full Text] [Related]
2. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
Song C; Duan C
Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
[TBL] [Abstract][Full Text] [Related]
4. HR+HER2- breast cancers with growth factor receptor-mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells.
Desai K; Aiyappa R; Prabhu JS; Nair MG; Lawrence PV; Korlimarla A; Ce A; Alexander A; Kaluve RS; Manjunath S; Correa M; Srinath BS; Patil S; Kalamdani A; Prasad M; Sridhar TS
Tumour Biol; 2017 Mar; 39(3):1010428317695028. PubMed ID: 28349782
[TBL] [Abstract][Full Text] [Related]
5. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
[TBL] [Abstract][Full Text] [Related]
6. FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.
Park J; Choi Y; Ko YS; Kim Y; Pyo JS; Jang BG; Kim MA; Lee JS; Chang MS; Park JW; Lee BL
Cancer Res Treat; 2018 Jan; 50(1):239-254. PubMed ID: 28343375
[TBL] [Abstract][Full Text] [Related]
7. The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition.
Shi J; Li F; Yao X; Mou T; Xu Z; Han Z; Chen S; Li W; Yu J; Qi X; Liu H; Li G
Oncogene; 2018 May; 37(22):3022-3038. PubMed ID: 29535422
[TBL] [Abstract][Full Text] [Related]
8. WAVE3 promotes epithelial-mesenchymal transition of gastric cancer through upregulation of Snail.
Yue Z; Feng W; Xiangke L; Liuxing W; Qingxia F; Jianbo G
Cancer Gene Ther; 2014 Dec; 21(12):499-506. PubMed ID: 25378074
[TBL] [Abstract][Full Text] [Related]
9. SNAIL regulates gastric carcinogenesis through CCN3 and NEFL.
Chen R; Masuo K; Yogo A; Yokoyama S; Sugiyama A; Seno H; Yoshizawa A; Takaishi S
Carcinogenesis; 2021 Feb; 42(2):190-201. PubMed ID: 33313663
[TBL] [Abstract][Full Text] [Related]
10. Increasing HER2 α2,6 sialylation facilitates gastric cancer progression and resistance via the Akt and ERK pathways.
Liu N; Zhu M; Linhai Y; Song Y; Gui X; Tan G; Li J; Liu Y; Deng Z; Chen X; Wang J; Jia L; He X; Wang X; Lin S
Oncol Rep; 2018 Nov; 40(5):2997-3005. PubMed ID: 30226606
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin resistance in gastric cancer cells is involved with GPR30-mediated epithelial-mesenchymal transition.
Wang X; Xu Z; Sun J; Lv H; Wang Y; Ni Y; Chen S; Hu C; Wang L; Chen W; Cheng X
J Cell Mol Med; 2020 Mar; 24(6):3625-3633. PubMed ID: 32052561
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.
Wang H; Zhang G; Zhang H; Zhang F; Zhou B; Ning F; Wang HS; Cai SH; Du J
Eur J Pharmacol; 2014 Jan; 723():156-66. PubMed ID: 24333218
[TBL] [Abstract][Full Text] [Related]
13. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
Zhao J; Yang C; Guo S; Wu Y
Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
[TBL] [Abstract][Full Text] [Related]
14. MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition.
Cao L; Wan Q; Li F; Tang CE
BMB Rep; 2018 Sep; 51(9):456-461. PubMed ID: 30037365
[TBL] [Abstract][Full Text] [Related]
15. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
16. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
17. TAZ overexpression is associated with epithelial-mesenchymal transition in cisplatin-resistant gastric cancer cells.
Ge L; Li DS; Chen F; Feng JD; Li B; Wang TJ
Int J Oncol; 2017 Jul; 51(1):307-315. PubMed ID: 28534974
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
19. Functional genetic approach identifies MET, HER3, IGF1R, INSR pathways as determinants of lapatinib unresponsiveness in HER2-positive gastric cancer.
Zhang Z; Wang J; Ji D; Wang C; Liu R; Wu Z; Liu L; Zhu D; Chang J; Geng R; Xiong L; Fang Q; Li J
Clin Cancer Res; 2014 Sep; 20(17):4559-73. PubMed ID: 24973425
[TBL] [Abstract][Full Text] [Related]
20. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
